U.S. market Closed. Opens in 1 day 12 hours 10 minutes

WVE | Wave Life Sciences Ltd. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for WVE we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is on medium level and Health is frighteningly weak.

Valuation (14%)

Company Industry
P/E Ratio (TTM) -26.42 -22.08
PEG Ratio (TTM) 2.75 15.66
P/S Ratio (TTM) 21.02 49.38
P/B Ratio (TTM) 441.58 18.85
P/FCF Ratio (TTM) -17.98 -3.07
Price to 5YR AVG Earnings Ratio -5.33 -3.42
Price to 5YR AVG FCF Ratio -21.16 -9.04

Profitability (25%)

Company Industry
ROA (TTM) -35.19% -5.15%
ROE (TTM) -657.91% 16.37%
Net Profit Margin (TTM) -66.50% -2,030.32%
ROIC 5YR AVG 168.03% 15.65%

Growth (57%)

4QTR AVG 3YR AVG 5YR AVG
EPS -64.61% 20.47% 29.64%
Revenue 20.47% 46.85% 610.91%
Net Income -72.06% 4.18% 8.93%
Cash Flow 7.28% -220.56% -124.10%

Health (16%)

Company Industry
Current Ratio (TTM) 0.99 6.19
Quick Ratio (TTM) 0.99 5.91
D/E Ratio (TTM) 6.57 -15.10
Interest Coverage (TTM) -29.06 -1.60
Piotroski F-Score 4 5
Altman Z-Score N/A 14.02
LTL to 5YR AVG FCF -0.23 0.18
Shares Outstanding Growth 5YR AVG 30.31% 123.85%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙